Fat Transfer Breast Augmentation

Before considering fat transfer, it’s important to set realistic expectations. Most patients see a modest increase of 1/2 to 1 cup size per session. The breast can only hold a certain amount of fat; injecting too much can lead to fat necrosis and a lower overall result. Studies show the average volume injected per breast is about 300 mL, with roughly 58% retained after one year. For larger increases, a staged approach with two sessions spaced three to six months apart is more effective than one aggressive procedure. Dr. Beck will evaluate your individual needs during the consultation.

Yes, this is crucial for fat transfer augmentation. The transferred fat cells are living tissue that react like fat in your body. Gaining weight can increase the volume of transferred fat in your breasts, while losing weight can cause it to shrink. Significant weight fluctuations can unpredictably affect your breast size and shape after the procedure.

Fat transfer breast augmentation does not affect mammogram ability or increase breast cancer risk. It’s essential to inform your imaging provider about the fat grafting before any mammogram, as it can lead to microcalcifications that appear as white spots on imaging. Experienced radiologists can usually distinguish benign from malignant findings. Additional imaging, such as ultrasound or MRI, may be recommended if needed. A baseline mammogram before surgery is advised, with follow-up imaging schedules remaining the same as for any patient.

Fat grafting in breast surgery can correct noticeable asymmetry by injecting fat into the smaller breast, improving balance without implants. This approach is ideal for those seeking a natural correction. Typically, results are modest in a single session, and a second session may be needed to achieve significant volume differences. Dr. Beck assesses asymmetry during consultation to recommend whether fat transfer alone or a combination approach will yield the best results.

Fat transfer is often described as a "natural" and therefore risk-free alternative to implants, but this oversimplification is misleading. Like any surgical procedure, it carries real risks that patients should understand clearly before deciding. The most clinically significant include:

• Fat resorption: The most predictable variable; a portion of the injected fat is naturally reabsorbed, reducing the final volume; this is anticipated in surgical planning but can still affect the result.
• Fat necrosis: When transferred fat cells fail to establish a blood supply and die, they can form firm, palpable lumps in the breast.
• Oil cysts and calcifications: Dead fat cells can liquefy into oil cysts or calcify over time, both of which are visible on breast imaging and may require evaluation to rule out malignancy.
• Contour irregularities: Uneven fat distribution can result in visible asymmetry or surface irregularities at both the donor and recipient sites.
• Donor site changes: Liposuction of the donor area carries its own risks, including bruising, swelling, contour deformity, numbness, and, rarely, hematoma or seroma.
• Infection: Uncommon but possible at either the harvest or injection sites.
• Bleeding or hematoma: Rare; more likely in patients with clotting disorders or who have not stopped blood-thinning medications before surgery.

Fat transfer to the breast is performed through tiny access points using fine cannulas, avoiding incisions near the areola and dissection of glandular tissue. Published studies show no decrease in nipple sensitivity or lactation, making it a favorable option for those concerned about future breastfeeding. Dr. Beck considers this advantage when advising on breast enhancement procedures.